Back to search
Radiocontrast-Induced Nephropathy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Radiocontrast-Induced Nephropathy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Radiocontrast-Induced Nephropathy trials you may qualify forMillions of people receive radiographic contrast material for investigations like CT and coronary angiography. While considered safe in healthy patients, it can…
In a prospective international multicenter observational study, 1080 stable chest pain patients (REALITY Advanced registry of CCTA patients) with the suspected…
This trial will evaluate whether treatment with CRMD001 (unique formulations of the iron chelator, Deferiprone) will reduce morbidity and mortality in subjects…
Full Title: A Randomized Controlled Trial of Procrit for the Prevention of Acute Renal Failure in Patients Receiving Intravenous Contrast Primary Objective: To…
* Contrast-induced nephropathy (CIN) is the third most common cause of hospital acquired acute kidney injury, accounting for 10% of all cases. * The pathophysio…
The contrast induced kidney toxicity has been known to affect the mortality and morbidity in the patients undergoing coronary angiography. But the mechanism and…